'Kettering cancer center' presentation slideshows

Prescription Drug Utilization & Opioid Abuse July 16, 2013

Prescription Drug Utilization & Opioid Abuse July 16, 2013 . Mona Chitre , PharmD , CGP Vice President, Pharmacy Management Excellus BlueCross BlueShield. Pharmacy Management: Market Landscape . Impact of Prescription Benefits Specialty Medications Price Increases

499 views • 33 slides

Living Longer: Colon Cancer Patients Gain Time With Radiofrequency Ablation Treatment

Living Longer: Colon Cancer Patients Gain Time With Radiofrequency Ablation Treatment. CT Sofocleous, EN Petre, M Gonen, KT Brown, RH Thornton, AM Covey, LA Brody, W Alago, M D'Angelica, SB Solomon, Y Fong, NE Kemeny. Memorial Sloan-Kettering Cancer Center, New York, NY

531 views • 23 slides

Positioning Turkey in Medical Tourism Hub

373 views • 22 slides

High-Dose Single-Fraction Radiotherapy for the Management of Chordomas of the Spine and Sacrum

High-Dose Single-Fraction Radiotherapy for the Management of Chordomas of the Spine and Sacrum. Yoshiya Yamada M.D., Ilya Laufer M.D., Brett W. Cox M.D., Michael D. Lovelock M.D., Robert G. Maki M.D. Ph. D., Joan M. Zatcky N.P., Patrick J. Boland M. D., Mark H. Bilsky M.D.

426 views • 21 slides

Policy, Guidelines, and Disparities

Policy, Guidelines, and Disparities. Peter B. Bach, MD, MAPP Memorial Sloan-Kettering Cancer Center bachp@mskcc.org. Overview. The goal of practice guidelines is to: Improve the quality of care? Manage care? Save money? Monitor the quality of care? Reduce disparities?

310 views • 21 slides

Memorial Sloan-Kettering Cancer Center, New York, NY

Adjuvant gemcitabine plus docetaxel for completely resected stage I-IV high grade uterine leiomyosarcoma: results of a phase II trial. Martee L. Hensley, Nicole Ishill, Robert Soslow, Nadeem Abu-Rustum, Paul Sabbatini, Jason Konner, William Tew, David Spriggs, Carol A. Aghajanian.

376 views • 21 slides

Addition of pamidronate to chemotherapy for treatment of osteosarcoma is feasible

Addition of pamidronate to chemotherapy for treatment of osteosarcoma is feasible . Meyers PA, Healey JH, Athanasian E, Boland P, Morris C, Laquaglia MP, Antonescu C, Wexler L, Merchant M, Merola P, Chou A, Abramson S, Kellick M Memorial Sloan-Kettering Cancer Center.

427 views • 19 slides

Big Data Definitions

257 views • 13 slides

1-year LRFS 89.4% 95%CI[85.0-92.5]) 2-year LRFS: 85.5% 95%CI[80.4-89.3])

Survival after resection plus intra-operative ablation to treat colorectal liver metastases (CLM): results of an international collaborative study.

82 views • 1 slides